Pipeline
Our pipeline
Diversified candidates with great potential
Our platform technologies can be used to discover and modify various biologics and applied to a wide range of disease areas. If you are interested in discussing partnerships using our platforms or on the below assets, please contact us.
| Candidates | Indication | Phase | Technology | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Discovery | Candidate ready | Preclinical | Phase 1 | Phase 2 | Phase 3 | ||||
| GT-02037 | Acromegaly | Endocrinology rare disease | now | Glycosylation | |||||
| GT-15019 | Multiple sclerosis | Autoimmune rare disease | now | Glycosylation | |||||
| GT-01123 | Type 2 diabetes | Endocrinology | now | Glycosylation | |||||
| TBA1 | Diabetes mellitus | Endocrinology | now | Glycosylation | |||||
| TBA2 | COVID-19 | Infection | now | Scaffold peptide | |||||